False-Negative Result for Cocaine Metabolites on a Lateral-Flow Drug Test Slide Corrected by Dilution
Author(s) -
Raffick A.R. Bowen,
David T. George,
Glen L. Hortin
Publication year - 2005
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2004.046607
Subject(s) - drug , dilution , chromatography , test (biology) , pharmacology , chemistry , medicine , biology , physics , paleontology , thermodynamics
Cocaine is one of the most widespread drugs of abuse; therefore, clinical laboratories are frequently requested to screen for the presence of cocaine and its metabolites in urine. When screening a urine specimen from a potential study participant for drugs of abuse, using a Verdict™ II lateral flow test slide (MEDTOX™ Diagnostics), multiple technologists obtained a negative screening result for benzoylecgonine (BE) on repeat analysis (n = 25). Because the study participant did not show symptoms of cocaine toxicity despite admitting to cocaine use and because the Verdict II drug test slide gave a negative result, the urine specimen was sent to Mayo Medical Laboratory (Rochester, MN) for a comprehensive drug screen and confirmation of cocaine and its metabolites by gas chromatography-mass spectrometry (Model 5973; Agilent™ Technologies) using solid-phase extraction and trimethylsilyl derivatization, as described by Chinn et al. (1). Gas chromatographic-mass spectrometric testing indicated that the urine …
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom